Herbert JM - Search Results

1

Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies.

Ahmad S, Jeske WP, Walenga JM, Hoppensteadt DA, Wood JJ, Herbert JM, Messmore HL, Fareed J. Ahmad S, et al. Among authors: herbert jm. Clin Appl Thromb Hemost. 1999 Oct;5(4):259-66. doi: 10.1177/107602969900500410. Clin Appl Thromb Hemost. 1999. PMID: 10726024 Free article.

2

Efficacy of pentasaccharide in a dog model of hemodialysis.

Hoppensteadt DA, Jeske WP, Walenga JM, Fu K, Yang LH, Ing T, Herbert JM, Fareed J. Hoppensteadt DA, et al. Among authors: herbert jm. Thromb Res. 1997 Oct 15;88(2):159-70. doi: 10.1016/s0049-3848(97)00227-2. Thromb Res. 1997. PMID: 9361369

3

Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets.

Jeske WP, Walenga JM, Szatkowski E, Ero M, Herbert JM, Haas S, Bakhos M. Jeske WP, et al. Among authors: herbert jm. Thromb Res. 1997 Nov 1;88(3):271-81. doi: 10.1016/s0049-3848(97)00254-5. Thromb Res. 1997. PMID: 9526947

4

Laboratory monitoring of pentasaccharide in a dog model of hemodialysis.

Hoppensteadt DA, Jeske WP, Walenga JM, Fu K, Yang LH, Ing TS, Herbert JM, Fareed J. Hoppensteadt DA, et al. Among authors: herbert jm. Thromb Res. 1999 Oct 15;96(2):115-24. doi: 10.1016/s0049-3848(99)00094-8. Thromb Res. 1999. PMID: 10574589

5

The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys.

Orcullo Santillan MK, Herring J, Hoppensteadt DA, Jeske W, Herbert JM, Fareed J. Orcullo Santillan MK, et al. Among authors: herbert jm. Clin Appl Thromb Hemost. 2001 Jan;7(1):10-5. doi: 10.1177/107602960100700103. Clin Appl Thromb Hemost. 2001. PMID: 11190897 Free article.

6

Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT2 antagonist (SR46349).

Yang LH, Callas D, Herbert JM, Fareed J. Yang LH, et al. Among authors: herbert jm. Thromb Res. 1996 Mar 1;81(5):555-67. doi: 10.1016/0049-3848(96)00030-8. Thromb Res. 1996. PMID: 8907314

7

Effect of SR121566A, a potent GP IIb-IIIa antagonist, on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells.

Herbert JM, Savi P, Jeske WP, Walenga JM. Herbert JM, et al. Thromb Haemost. 1998 Aug;80(2):326-31. Thromb Haemost. 1998. PMID: 9716161 Clinical Trial.

8

Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats.

Hérault JP, Perrin B, Jongbloet C, Pflieger AM, Bernat A, Herbert JM. Hérault JP, et al. Among authors: herbert jm. Thromb Haemost. 2000 Oct;84(4):668-74. Thromb Haemost. 2000. PMID: 11057868

9

Determination of the anti-factor Xa activity of the synthetic pentasaccharide SR 90107A/ORG 31540 and of two structural analogues.

Lormeau JC, Herault JP, Gaich C, Barzu T, van Dinther TG, Visser A, Herbert JM. Lormeau JC, et al. Among authors: herbert jm. Thromb Res. 1997 Jan 1;85(1):67-75. doi: 10.1016/s0049-3848(96)00223-x. Thromb Res. 1997. PMID: 8983127

10

Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.

Lormeau JC, Herault JP, Herbert JM. Lormeau JC, et al. Among authors: herbert jm. Thromb Haemost. 1996 Jul;76(1):5-8. Thromb Haemost. 1996. PMID: 8819242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters